Literature DB >> 29905079

Untargeted Profiling of Concordant/Discordant Phenotypes of High Insulin Resistance and Obesity To Predict the Risk of Developing Diabetes.

Anna Marco-Ramell, Sara Tulipani1, Magali Palau-Rodriguez, Raul Gonzalez-Dominguez, Antonio Miñarro, Olga Jauregui2, Alex Sanchez-Pla3, Manuel Macias-Gonzalez1, Fernando Cardona1, Francisco J Tinahones1, Cristina Andres-Lacueva.   

Abstract

This study explores the metabolic profiles of concordant/discordant phenotypes of high insulin resistance (IR) and obesity. Through untargeted metabolomics (LC-ESI-QTOF-MS), we analyzed the fasting serum of subjects with high IR and/or obesity ( n = 64). An partial least-squares discriminant analysis with orthogonal signal correction followed by univariate statistics and enrichment analysis allowed exploration of these metabolic profiles. A multivariate regression method (LASSO) was used for variable selection and a predictive biomarker model to identify subjects with high IR regardless of obesity was built. Adrenic acid and a dyglyceride (DG) were shared by high IR and obesity. Uric and margaric acids, 14 DGs, ketocholesterol, and hydroxycorticosterone were unique to high IR, while arachidonic, hydroxyeicosatetraenoic (HETE), palmitoleic, triHETE, and glycocholic acids, HETE lactone, leukotriene B4, and two glutamyl-peptides to obesity. DGs and adrenic acid differed in concordant/discordant phenotypes, thereby revealing protective mechanisms against high IR also in obesity. A biomarker model formed by DGs, uric and adrenic acids presented a high predictive power to identify subjects with high IR [AUC 80.1% (68.9-91.4)]. These findings could become relevant for diabetes risk detection and unveil new potential targets in therapeutic treatments of IR, diabetes, and obesity. An independent validated cohort is needed to confirm these results.

Entities:  

Keywords:  ROC curves; adrenic acid; diglycerides; insulin resistance; metabolic profiles; metabolomics; obesity; observational study; predictive model; uric acid

Mesh:

Substances:

Year:  2018        PMID: 29905079     DOI: 10.1021/acs.jproteome.7b00855

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  7 in total

1.  Gestational diabetes mellitus is associated with the neonatal gut microbiota and metabolome.

Authors:  Ting Chen; Yufeng Qin; Minjian Chen; Yuqing Zhang; Xu Wang; Tianyu Dong; Guanglin Chen; Xian Sun; Ting Lu; Richard Allen White; Peng Ye; Hein M Tun; Yankai Xia
Journal:  BMC Med       Date:  2021-05-27       Impact factor: 8.775

2.  Are we close to defining a metabolomic signature of human obesity? A systematic review of metabolomics studies.

Authors:  Oscar Daniel Rangel-Huerta; Belén Pastor-Villaescusa; Angel Gil
Journal:  Metabolomics       Date:  2019-06-13       Impact factor: 4.290

3.  Latent-period stool proteomic assay of multiple sclerosis model indicates protective capacity of host-expressed protease inhibitors.

Authors:  Carlos G Gonzalez; Stephanie K Tankou; Laura M Cox; Ellen P Casavant; Howard L Weiner; Joshua E Elias
Journal:  Sci Rep       Date:  2019-08-28       Impact factor: 4.379

4.  Study on the Antihypertensive Mechanism of Astragalus membranaceus and Salvia miltiorrhiza Based on Intestinal Flora-Host Metabolism.

Authors:  Cong Han; Yue-Hua Jiang; Wei Li; Yao Liu; Zhen-Qiang Qi
Journal:  Evid Based Complement Alternat Med       Date:  2019-07-21       Impact factor: 2.629

Review 5.  Omics Biomarkers in Obesity: Novel Etiological Insights and Targets for Precision Prevention.

Authors:  Krasimira Aleksandrova; Caue Egea Rodrigues; Anna Floegel; Wolfgang Ahrens
Journal:  Curr Obes Rep       Date:  2020-09

6.  Translating insights from the seed metabolome into improved prediction for lipid-composition traits in oat (Avena sativa L.).

Authors:  Malachy T Campbell; Haixiao Hu; Trevor H Yeats; Melanie Caffe-Treml; Lucía Gutiérrez; Kevin P Smith; Mark E Sorrells; Michael A Gore; Jean-Luc Jannink
Journal:  Genetics       Date:  2021-03-31       Impact factor: 4.562

7.  The relationship between the effect of matured hop extract and physical activity on reducing body fat: re-analysis of data from a randomized, double-blind, placebo-controlled parallel group study.

Authors:  Shigeo Suzuki; Takahiro Yamazaki; Chika Takahashi; Yuji Kaneko; Yumie Morimoto-Kobayashi; Mikio Katayama
Journal:  Nutr J       Date:  2018-10-30       Impact factor: 3.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.